Gabelli & Co Investment Advisers’s Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 QFTA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding QFTA.WS
RCM
HCM
RCM
CS
SIA
SFM
FTUS
Gabelli & Co Investment Advisers's QFTA.WS Position: Q4 2022 in Review
Gabelli & Co Investment Advisers sold out of Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 (QFTA.WS) in Q4 2022, closing a stake of 180,000 shares — an estimated $7K sold.
Gabelli & Co Investment Advisers first reported a position in QFTA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $92K in Q4 2021. 7 funds tracked by Wall St. Rank hold QFTA.WS as of Q4 2022.
- Gabelli & Co Investment Advisers reported no remaining Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 180,000 Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 shares in Q4 2022, an estimated $7K.
- Gabelli & Co Investment Advisers first reported a position in Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 in Q2 2021 and held it in 6 quarters.
- Gabelli & Co Investment Advisers's Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 position peaked at $92K in Q4 2021.
- 7 funds tracked by Wall St. Rank held Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50 as of Q4 2022.
Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2022, filed 13 Feb 2023.